Authors:
SMITH AB
HIRSCHMANN R
PASTERNAK A
AKAISHI R
GUZMAN MC
JONES DR
KEENAN TP
SPRENGELER PA
DARKE PL
EMINI EA
HOLLOWAY MK
SCHLEIF WA
Citation: Ab. Smith et al., DESIGN AND SYNTHESIS OF PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE AND RENIN - EVIDENCE FOR IMPROVED TRANSPORT, Journal of medicinal chemistry, 37(2), 1994, pp. 215-218
Authors:
TUCKER TJ
LYLE TA
WISCOUNT CM
BRITCHER SF
YOUNG SD
SANDERS WM
LUMMA WC
GOLDMAN ME
OBRIEN JA
BALL RG
HOMNICK CF
SCHLEIF WA
EMINI EA
HUFF JR
ANDERSON PS
Citation: Tj. Tucker et al., SYNTHESIS OF A SERIES OF ORO-4-CYCLOPROPYL-3,4-DIHYDROQUINAZOLIN-2(1H)-ONES AS NOVEL NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS, Journal of medicinal chemistry, 37(15), 1994, pp. 2437-2444
Authors:
SCHLEIF WA
SARDANA VV
BYRNES VW
MURTHY KK
EMINI EA
Citation: Wa. Schleif et al., PREVENTION OF HIV-1 INFECTION IN CHIMPANZEES BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, Journal of cellular biochemistry, 1993, pp. 23-23
Authors:
BYRNES VW
SARDANA VV
CONDRA JH
SCHLEIF WA
SCHNEIDER CL
WATERBURY JA
WOLFGANG JA
GRAHAM DJ
GOTLIB L
SCHLABACH AJ
WOLANSKI BS
LONG WJ
RHODES A
TITUS DL
ROTH E
BLAHY OM
EMINI EA
Citation: Vw. Byrnes et al., HIV-1 REVERSE-TRANSCRIPTASE RESIDUES THAT INFLUENCE SENSITIVITY TO NONNUCLEOSIDE INHIBITORS, Journal of cellular biochemistry, 1993, pp. 75-75
Authors:
BYRNES VW
SARDANA VV
SCHLEIF WA
CONDRA JH
WATERBURY JA
WOLFGANG JA
LONG WJ
SCHNEIDER CL
SCHLABACH AJ
WOLANSKI BS
GRAHAM DJ
GOTLIB L
RHODES A
TITUS DL
ROTH E
BLAHY OM
QUINTERO JC
STASZEWSKI S
EMINI EA
Citation: Vw. Byrnes et al., COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1576-1579
Authors:
GOLDMAN ME
OBRIEN JA
RUFFING TL
SCHLEIF WA
SARDANA VV
BYRNES VW
CONDRA JH
HOFFMAN JM
EMINI EA
Citation: Me. Goldman et al., A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR ACTIVE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO RELATED INHIBITORS, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 947-949
Authors:
SAAG MS
EMINI EA
LASKIN OL
DOUGLAS J
LAPIDUS WI
SCHLEIF WA
WHITLEY RJ
HILDEBRAND C
BYRNES VW
KAPPES JC
ANDERSON KW
MASSARI FE
SHAW GM
Citation: Ms. Saag et al., A SHORT-TERM CLINICAL-EVALUATION OF L-697,661, A NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE, The New England journal of medicine, 329(15), 1993, pp. 1065-1072
Authors:
WILLIAMS TM
CICCARONE TM
MACTOUGH SC
ROONEY CS
BALANI SK
CONDRA JH
EMINI EA
GOLDMAN ME
GREENLEE WJ
KAUFFMAN LR
OBRIEN JA
SARDANA VV
SCHLEIF WA
THEOHARIDES AD
ANDERSON PS
Citation: Tm. Williams et al., 5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE, Journal of medicinal chemistry, 36(9), 1993, pp. 1291-1294
Authors:
HOFFMAN JM
SMITH AM
ROONEY CS
FISHER TE
WAI JS
THOMAS CM
BAMBERGER DL
BARNES JL
WILLIAMS TM
JONES JH
OLSON BD
OBRIEN JA
GOLDMAN ME
NUNBERG JH
QUINTERO JC
SCHLEIF WA
EMINI EA
ANDERSON PS
Citation: Jm. Hoffman et al., SYNTHESIS AND EVALUATION OF 2-PYRIDINONE DERIVATIVES AS HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS .4. AZOL-2-YL)ETHYL]-5-ETHYL-6-METHYLPYRIDIN-2(1H)-ONE AND ANALOGS, Journal of medicinal chemistry, 36(8), 1993, pp. 953-966
Authors:
GHOSH AK
THOMPSON WJ
HOLLOWAY MK
MCKEE SP
DUONG TT
LEE HY
MUNSON PM
SMITH AM
WAI JM
DARKE PL
ZUGAY JA
EMINI EA
SCHLEIF WA
HUFF JR
ANDERSON PS
Citation: Ak. Ghosh et al., POTENT HIV PROTEASE INHIBITORS - THE DEVELOPMENT OF TETRAHYDROFURANYLGLYCINES AS NOVEL P(2)-LIGANDS AND PYRAZINE AMIDES AS P(3)-LIGANDS, Journal of medicinal chemistry, 36(16), 1993, pp. 2300-2310